logo
‘Why I think a long life might not always mean a better life'

‘Why I think a long life might not always mean a better life'

News.com.au30-05-2025
OPINION
Who decided that a long life is the best life?
I get that people are afraid of death because at least you know what's happening in this world – but do you really want to live forever?
Sam of Melbourne recently wrote into news.com.au's Ask Doctor Zac column, prompted by the ubiquitous democracy sausage pushed by school fundraising groups on election day, to inquire whether he was at risk of developing cancer due to his love of processed meats.
Dr Turner's advice was that you don't have to give up on the snags entirely but one should keep in mind that 'even small daily amounts of processed meat (just 50g a day – that's two slices of ham) can increase your risk of bowel cancer by 18 per cent'.
And to that I say – so what?
We're all going to die. Death and people who drive 20km/h under the limit speeding up when they come to an overtaking lane. There's nothing surer.
So why sit around worrying about what it is that will eventually claim your life?
Perhaps if your diet consists exclusively of sausages and bacon, washed down with lashings of chocolate milk, then you ought to reconsider your habits but, otherwise, stop worrying about it.
If they had it their way, public health zealots would rid the world of anything remotely fun or tasty because... well, to be honest, I'm quite sure why.
I do know that if they had their way it would sap most of us of the will to live, which is rather ironic.
The official recommendations for treating your body like a temple are comical.
You should have precisely zero cigarettes ever because 'every cigarette is doing you damage'.
And that may well be true but let's be real – it's not people who had a few durries on the weekend in their 20s who are dropping with lung cancer.
The World Health Organisation deems processed meat a Group 1 carcinogen which, as a racing man, led me to think they must be the best carcinogen.
From a taste perspective, I was right.
Red meat is a Group 2A carcinogen which means it probably causes bowel cancer.
The Cancer Council says you should only eat 455g of cooked, lean red meat every week and suggests that 400g of raw red meat, once cooked, is enough to feed a family of four.
Perhaps a family of four toddlers.
They recommend that you 'eat little, if any, processed meat'.
The Health Department says you should have no more than 10 standard drinks a week.
That makes your allotment six schooners of beer a week, or a bit more than a bottle of wine.
And God forbid you have more than four standard drinks in one sitting because, under government guidelines, that makes you a binge drinker.
A standard glass of wine is about 1.5 standard drinks so one glass before dinner, one with and one after – which would be pretty standard for a lot of people – and you're in trouble.
I often joke that I treat my body like a temple – I desecrate it.
I'm not interested in making sure I live forever because I'm far more inclined to enjoy myself while I have breath in my lungs.
To me, clean living is showering twice a day.
As the saying goes – I'm here for a good time, not a long time.
That doesn't mean I want to drop dead tomorrow and I would take precautions if I was told that was likely but I'm not stressed about my mortality.
I drink quite a bit of red wine, I like a few pints before lunch, I eat quite a bit of blue cheese and I go through at least two cans of Coke Zero a day (sometimes mixed with bourbon).
If that shaves five years off my life then so be it.
I'd rather have fun than fastidiously look after my body so I can live to 98 – only to discover that I'm demented and can't remember my family anymore because we weren't designed to live that long.
If you're enjoying yourself, and you're not causing anyone else harm, then play on.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Strategic CEO hire to drive NeuroScientific stem cell therapy release
Strategic CEO hire to drive NeuroScientific stem cell therapy release

The Age

time3 minutes ago

  • The Age

Strategic CEO hire to drive NeuroScientific stem cell therapy release

NeuroScientific Biopharmaceuticals has made a second heavy-hitting appointment in less than a week, bringing in experienced Melbourne-based executive Nathan Smith as its chief executive officer, as the company gears up for the commercial release of its innovative StemSmart stem cell technology. Smith has extensive experience in cell and gene therapies in senior commercial, operational and strategic roles in Australia and the United States, which should prove invaluable as the company navigates the regulatory and commercial pathways for its innovative StemSmart technology. The company says his deep expertise in good practice manufacturing will be critical for converting the biotechnology startup into a scaled-up commercial stem cell company. NeuroScientific acquired the StemSmart technology in late June via its $4.1 million acquisition of unlisted Perth-based stem cell company Isopgen. StemSmart uses a specific type of stem cell, mesenchymal stromal stem cells (MSC), as a last-line infusion treatment for critically ill patients, including those experiencing severe immune complications from bone marrow transplants, kidney and lung transplant rejection and inflammatory Crohn's disease. 'I was attracted to NSB given the historical success of StemSmart in multiple serious clinical disorders and the clear potential of the technology for further development.' NeuroScientific Biopharmaceuticals chief executive officer Nathan Smith Adding to the company's ranks of highly credentialled personnel, NeuroScientific announced on Friday that it had also recruited well-regarded Perth-based paediatric haematologist and oncologist Dr Catherine Cole as its chief medical officer. The news of both appointments has continued to fuel a stellar rise in the company's share price, which traded 11.3 per cent higher today to 24.5 cents on the best turnover since April. The company's share price is up 360 per cent since the start of June. Smith was the director of business development at Melbourne's Cell Therapies, which develops and manufactures advanced cell-based therapies and is located within the city's pioneering Peter MacCallum Cancer Centre. He has held key roles at Genzyme Corporation, Mesoblast Inc and GlaxoSmithKline in the US, as well as other leading companies in the cell therapy sector.

Strategic CEO hire to drives NeuroScientific stem cell therapy release
Strategic CEO hire to drives NeuroScientific stem cell therapy release

West Australian

time3 minutes ago

  • West Australian

Strategic CEO hire to drives NeuroScientific stem cell therapy release

NeuroScientific Biopharmaceuticals has made a second heavy-hitting appointment in less than a week, bringing in experienced Melbourne-based executive Nathan Smith as its chief executive officer, as the company gears up for the commercial release of its innovative StemSmart stem cell technology. Smith has extensive experience in cell and gene therapies in senior commercial, operational and strategic roles in Australia and the United States, which should prove invaluable as the company navigates the regulatory and commercial pathways for its innovative StemSmart technology. The company says his deep expertise in good practice manufacturing will be critical for converting the biotechnology startup into a scaled-up commercial stem cell company. NeuroScientific acquired the StemSmart technology in late June via its $4.1 million acquisition of unlisted Perth-based stem cell company Isopgen. StemSmart uses a specific type of stem cell, mesenchymal stromal stem cells (MSC), as a last-line infusion treatment for critically ill patients, including those experiencing severe immune complications from bone marrow transplants, kidney and lung transplant rejection and inflammatory Crohn's disease. Adding to the company's ranks of highly credentialled personnel, NeuroScientific announced on Friday that it had also recruited well-regarded Perth-based paediatric haematologist and oncologist Dr Catherine Cole as its chief medical officer. The news of both appointments has continued to fuel a stellar rise in the company's share price, which traded 11.3 per cent higher today to 24.5 cents on the best turnover since April. The company's share price is up 360 per cent since the start of June. Smith was the director of business development at Melbourne's Cell Therapies, which develops and manufactures advanced cell-based therapies and is located within the city's pioneering Peter MacCallum Cancer Centre. He has held key roles at Genzyme Corporation, Mesoblast Inc and GlaxoSmithKline in the US, as well as other leading companies in the cell therapy sector. NeuroScientific says that having led programs across their full therapeutic cycle, including pre-clinical development and clinical trials, Smith has extensive experience in navigating regulatory approvals and developing commercial product supplies. Smith said he was excited to help advance the technology and make it accessible to patients with serious and life-threatening conditions. 'I was attracted to NSB given the historical success of StemSmart in multiple serious clinical disorders and the clear potential of the technology for further development,' he said. The high-level executive duo of Smith and Cole join a strong leadership team, which also includes Perth-based haematology medical scientist Dr Marian Sturm, as NeuroScientific's chief scientific officer. Sturm pioneered the use of the MSC used in StemSmart over the past 20 years in her former role as facility director of Royal Perth Hospital's Cell and Tissue Therapies centre. StemSmart offers a step up from traditional MSC manufacturing in that the cells are grown in a special media, becoming activated in the process. The platform technology was developed at Royal Perth Hospital and manufactured using the hospital's processes. The cells have been used many times over the years via early-phase clinical trials, studies and on compassionate grounds, with promising results. Later in the year, the company expects to receive the interim results from its latest compassionate trial involving patients with difficult-to-treat fistulising Crohn's disease, in which an open wound develops from a gut flare-up that extends out to the skin. A successful trial will help the company validate its proprietary StemSmart technology in this patient group, who otherwise have limited treatment options. NeuroScientific has created a bit of a whirlwind this year with its Isopogen acquisition, re-energised leadership team and a $3.5 million capital raise. The funding has handed the company a $7.5 million war chest to support further trials and development and helped it generate plenty of momentum towards its long-term goal of partial or full registration for StemSmart, first up as a Crohn's treatment. Is your ASX-listed company doing something interesting? Contact:

Victorian Aboriginal woman Heather Calgaret's death in custody was preventable, coroner finds
Victorian Aboriginal woman Heather Calgaret's death in custody was preventable, coroner finds

ABC News

time3 minutes ago

  • ABC News

Victorian Aboriginal woman Heather Calgaret's death in custody was preventable, coroner finds

From behind bars, Heather Calgaret wrote to loved ones that she wanted to leave prison behind and become a "better person", to make her children proud. NOTE: This story uses images of Heather Calgaret with the permission of her family. "I look back with sadness rather than hate. I look forward with hope rather than despair," she wrote. But the 30-year-old never got the chance to fulfil her dream of rebuilding a life in the community before her death in November 2021. On Monday, coroner Sarah Gebert found that death was preventable and came after a litany of missed opportunities to support the Aboriginal woman's health in Melbourne's Dame Phyllis Frost prison. "Not only was Heather's passing preventable, she should never have passed in the manner she did," Ms Gebert said. The coronial inquest heard Heather was less than 10 weeks from completing a sentence for armed robbery when her sister Suzanne Calgaret, who was living in the same prison unit, was unable to rouse her ahead of the daily check-in. Ms Gebert said after the alert was raised in the prison, Heather was rushed to Sunshine Hospital, but she had already suffered an irreversible brain injury. The coroner found the passing of the Noongar, Yamatji, Wongi and Pitjantjatjara woman after respiratory failure was the preventable result of inappropriately prescribed medication the day before. She found the doctor who prescribed the injection of the opioid substitution drug buprenorphine did not follow guidelines in place to ensure Heather would be able to tolerate the drug. Heather had sought access to opioid substitution therapies because she wanted to ensure she would stay off drugs after her release from prison just weeks later, the inquest heard. Ms Gebert said usually, a patient would receive another drug — suboxone — for five days before beginning treatment with buprenorphine, as a stabilising step. In Heather's case, this did not happen because the doctor believed she had already been using suboxone in prison, relying on self-reported use by Heather. But the coroner found the doctor could not have been "reasonably satisfied" by this assumption. Ms Gebert said the prescription of the injection of buprenorphine was therefore "inappropriate". The court heard the departure from prescribing protocol was not communicated by the doctor to nurses, who may have otherwise been more vigilant in monitoring after treatment. "I consider that but for the administration of [buprenorphine], Heather would not have passed," Ms Gebert said. During the delivery of her findings, the at-times emotional coroner acknowledged the three other Aboriginal women who had been in the same prison unit with Heather, including her sister Suzanne. "I acknowledge those women who supported each other and were each other's family during their incarcerations," she said. "They unfortunately witnessed the unspeakable which occurred in their unit: the passing of a loved one and another death in custody. 'It is my hope that the manner in which Heather passed does not overshadow her spirit or her tremendous life of value." In findings running to almost 300 pages, the coroner also identified "numerous issues" of concern relating to the way Heather's parole assessment was managed. She recommended the agencies involved in Heather's journey through the justice system reflect on why the standards of care and fairness laid down in policies and called for by past commissions and the Yoorrook truth-telling inquiry had, at times, not been met. Speaking before the findings were handed down, Heather's family told the ABC they were still struggling to process the loss of their "rock", who had filled their lives with love and laughter. "She was the best older sister," her youngest brother Rory Smith said. He said Heather had been going through a "rough time" when she went into prison — in part because child protection authorities had taken custody of her children — but that did not define her. "Her kids were literally her world," he said. "If she would have gotten parole she would still be here today." In her findings, Ms Gebert noted an "insightful" letter written by Heather in which she put forward her case for parole. In it, the mother of four noted that she had been told that in order to complete parole she needed to finish a rehabilitation program, but the prison was not running any sessions in the near future. "I guess what I'm trying to say, is if Dame Phyllis is not running the See Change program, is there any possibility of completing this on the outside, in the community," Heather wrote. The coroner said the inquest had heard there was a "cruel Kafkian circularity" in the requirement to complete a particular program to be eligible for parole, when no such program was available. Ms Gebert said while parole was never guaranteed for prisoners, it was reasonable to expect that the justice system should be able to facilitate the sentences handed down by judges after close scrutiny of each individual case. She also noted that Heather's suggestion that she could live with her mother was judged "unsuitable" during her parole assessment, but there was no evidence that authorities had previously raised concerns about the address. While in prison, Heather gave birth to her fourth child and applied to have her baby live with her in the prison's mother-and-baby unit. That application was rejected, in a decision that was not within the scope of the coronial inquest — although one expert told the court that allowing Heather and her child to remain together may offered an opportunity to break a cycle. Heather's mother, Aunty Jenny Calgaret, said the decision by authorities to take Heather's newborn child from her would have "crushed" her. "She was so excited when she was pregnant … she couldn't wait to have the baby and she was confident that she was going to keep the baby in the prison with her," Aunty Jenny said. The coronial inquest heard that in the aftermath of the removal, Heather began self-medicating with food, gaining a significant amount of weight as her mental health declined. Ms Gebert said the inquest had heard her condition required "urgent mental health treatment" that she was unlikely to get in prison. "There were many missed opportunities throughout that time to intervene [on] Heather's health decline," she said. During her time in prison, Heather turned to visual art to express herself, producing a series of paintings which she shared with family and sold through the not-for-profit Torch art program. "She used to ring all the time and tell us, 'I sold another painting today'," Aunty Jenny said. "I was really happy and proud for her." Aunty Jenny said the vibrant compositions were now a reminder of her beautiful, funny daughter, who had been filled with laughter and love for her family. "I see Heather. I see her, straight away. It's her all over," Aunty Jenny said. After Monday's hearing, Heather's sister Suzanne said the family hoped lessons would be learnt to prevent similar deaths in future. "[For prison health workers] to be aware of just how strong the opioids can be, especially for those who are on it and who do need it, it can happen to any which one of them," she said. "Life is precious, that's what we all need to realise. Once you're gone, you're gone." The Victorian Minister for Corrections has been contacted for comment.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store